Basic Information
Basic information for C21orf62-AS1-203-51aa
Peptide Name C21orf62-AS1-203-51aa
Genome Position chr21:32798427-32798579[+]
Species Human
Peptide Sequence MICKGTCSPHDLTPILTPRVHDSLFCWRLCLKTSSPSFSQVPLVSCDFTGL
Peptide Length 51
Unique No (C21orf62-AS1-201-51aa)
Grand Average of Hydropathicity 0.2941
Relative Molecular Mass 6540.55
Experimental Evidences no
lncRNA ID/Name ENSG00000205930;C21orf62-AS1
Transcript ID/Name ENST00000382378;C21orf62-AS1-203
Transcript Length 3352
Coding Ability 0.4538
DNA Sequence Corresponding to Peptide ATGATATGCAAAGGCACCTGTTCTCCTCATGACCTAACCCCAATTCTTACTCCACGGGTTCATGACAGCCTATTCTGCTGGAGACTGTGTCTTAAAACTTCCTCCCCTAGTTTCTCTCAAGTACCCCTCGTGAGCTGTGATTTCACTGGGCTT
Experimental Evidences
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :